z-logo
open-access-imgOpen Access
Antiretroviral Boosting Agent Cobicistat Increases the Pharmacokinetic Exposure and Anticoagulant Effect of Dabigatran in HIV-Negative Healthy Volunteers
Author(s) -
Lori A. Gordon,
Parag Kumar,
Kristina M. Brooks,
Anela Kellogg,
Maryellen McManus,
Raul M. Alfaro,
Khanh Nghiem,
Jomy George,
Jay N. Lozier,
Scott Penzak,
Colleen Hadigan
Publication year - 2016
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.116.025257
Subject(s) - medicine , pharmacy , cobicistat , clinical pharmacy , dabigatran , human immunodeficiency virus (hiv) , family medicine , warfarin , antiretroviral therapy , viral load , atrial fibrillation

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom